South Korea
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.87 B
|
Dec. 31, 2023 | USD 10.34 | -1.02% |
|
South Korea |
|
2 |
USD 2.03 B
|
Dec. 31, 2023 | USD 108.37 | -2.33% |
|
South Korea |
|
3 |
USD 1.42 B
|
Dec. 31, 2023 | USD 33.55 | -1.07% |
|
South Korea |
|
4 |
USD 116.59 M
|
Dec. 31, 2023 | USD 8.48 | -0.62% |
|
South Korea |
|
5 |
USD 58.92 M
|
Dec. 31, 2023 | USD 1.84 | -0.37% |
|
South Korea |
|
6 |
USD 49.09 M
|
Dec. 31, 2023 | USD 3.90 | -0.31% |
|
South Korea |
The Vaccines company in South Korea with the highest Total Assets is Green Cross Holdings Corporation (KSE: 005250.KS) at USD 2.87 B.
The Vaccines company in South Korea with the lowest Total Assets is Cellid, Co., Ltd. (KOSDAQ: 299660.KQ) at USD 49.09 M.
The top 10 Vaccines companies in South Korea by Total Assets are Green Cross Holdings Corporation, Green Cross Corporation, SK bioscience Co.,Ltd., EuBiologics Co., Ltd., SillaJen, Inc. and Cellid, Co., Ltd..
The bottom 10 Vaccines companies in South Korea by Total Assets are Cellid, Co., Ltd., SillaJen, Inc., EuBiologics Co., Ltd., SK bioscience Co.,Ltd., Green Cross Corporation and Green Cross Holdings Corporation.